Molecular diagnostics in pathology

被引:9
|
作者
Stenzinger, A. [1 ]
Penzel, R. [1 ]
Endris, V. [1 ]
Weichert, W. [1 ,2 ]
机构
[1] Univ Klinikum Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany
[2] Natl Ctr Tumorerkrankungen, Heidelberg, Germany
关键词
pathology; molecular diagnostics; tissue; pathogenic organisms; immunohistochemistry; sequencing; mutations; oncology; CANCER; BIOMARKERS; GENOMICS;
D O I
10.1055/s-0033-1343106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue-based molecular diagnostics is a fast growing diagnostic field, which already complements morphologic classifications in many cases. Pathology based molecular diagnosis is performed almost exclusively on paraffin embedded material and always in conjunction with histopathology. Besides the classic field of tissue based detection of pathogenic organisms such as bacteria, viruses and fungi, molecular diagnostics of tumor tissue is one of the current hot topics in oncology. In this context the detection of predictive molecular biomarkers, such as specific mutations, allows patient stratification for individually tailored treatment strategies and thereby is one of the key components of individualized patient care in oncology. The rapidly growing number of clinically relevant predictive biomarkers together with impressive technical advances, specifically the development of massive parallel sequencing, will modify the care of patients with malignant diseases. Pathology, therefore, has returned in the very center of interdisciplinary patient care. © Georg Thieme Verlag KG · Stuttgart · New York.
引用
收藏
页码:1061 / 1068
页数:8
相关论文
共 50 条
  • [41] Molecular profiling and companion diagnostics: where is personalized medicine in cancer heading?
    Verma, Mukesh
    PERSONALIZED MEDICINE, 2014, 11 (08) : 761 - 771
  • [42] Pathology and Molecular Biology of Melanoma
    Timis, Tanase
    Bergthorsson, Jon Thor
    Greiff, Victor
    Cenariu, Mihai
    Cenariu, Diana
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (07) : 5575 - 5597
  • [43] Molecular diagnostics of hepatobiliary and pancreatic neoplasias
    Longerich, T.
    Stenzinger, A.
    Schirmacher, P.
    VIRCHOWS ARCHIV, 2024, 484 (02) : 263 - 272
  • [44] From molecular diagnostics to personalized testing
    Finan, Jon E.
    Zhao, Richard Y.
    PHARMACOGENOMICS, 2007, 8 (01) : 85 - 99
  • [45] Mesothelioma: molecular pathology and biomarkers
    Hung, Yin P.
    PATHOLOGIE, 2024, 45 (05): : 316 - 323
  • [46] Molecular diagnostics of gliomas: state of the art
    Riemenschneider, Markus J.
    Jeuken, Judith W. M.
    Wesseling, Pieter
    Reifenberger, Guido
    ACTA NEUROPATHOLOGICA, 2010, 120 (05) : 567 - 584
  • [47] Molecular Diagnostics of Vascular Tumors of the Skin
    Llamas-Velasco, Mar
    Mentzel, Thomas
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2020, 42 (11) : 799 - 810
  • [48] The applications of metabolomics in the molecular diagnostics of cancer
    Cheung, Pro Kit
    Ma, Man Hin
    Tse, Hing Fung
    Yeung, Ka Fai
    Tsang, Hin Fung
    Chu, Man Kee Maggie
    Kan, Chau Ming
    Cho, William Chi Shing
    Ng, Lawrence Bo Wah
    Chan, Lawrence Wing Chi
    Wong, Sze Chuen Cesar
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (09) : 785 - 793
  • [49] Molecular diagnostics of hepatobiliary and pancreatic neoplasias
    T. Longerich
    A. Stenzinger
    P. Schirmacher
    Virchows Archiv, 2024, 484 : 263 - 272
  • [50] Contemporary Diagnostics: Sarcoma Pathology Update
    Brooks, John S. J.
    Lee, Solomon
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (05) : 513 - 519